Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell
by on Wednesday, August 8th, 2012 | No Comments
Conditions: Myeloid Leukemia, Chronic; Acute Myelogenous Leukemia; Myelodysplastic Syndromes (MDS); Lymphoma, Non-Hodgkin
Intervention: Biological: Conventional T cells (Tcon) and Regulatory T cells (Treg)
Sponsors: Stanford University; Ginna Laport; National Institutes of Health (NIH)
Recruiting – verified August 2012
Original post: Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell